Skip to main navigation

Home
Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Press Releases

Press Releases

Year

May 29, 2024

Athira Pharma to Participate in Upcoming June Conferences

May 17, 2024

Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action

May 15, 2024

Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates

May 2, 2024

Athira Pharma to Participate in Upcoming May Conferences

April 15, 2024

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

April 11, 2024

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease

April 3, 2024

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

March 8, 2024

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference

February 22, 2024

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

February 8, 2024

Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 11 - 20 of 139

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

info@athira.com

© Athira Pharma, Inc. All rights reserved.